Market Research Reports and Industry Reports

Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies

There are more than 1400 sustained or controlled release drugs approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of the overall international pharmaceutical market. Utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.
The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectable only drugs. Global injectable drug delivery market is expected to be worth $29b by 2015.

Novel drug delivery systems (NDDS) offer many more advantages, which include improved therapy by increasing the efficacy and duration of drug activity, increased patient compliance through decreased dosing frequency and convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. The challenge for both drug and drug delivery companies is to deliver both existing and emerging drug technologies in a manner that improves the current benefits enjoyed by the patients.

The generic market with reference to innovative molecule (NCE) has become very competitive as several companies have already filed ANDAs for potential generic drugs in the near term. The study of the novel drug delivery companies and their formulation technologies will provide the potential value added opportunity in the generic field in terms of patients compliance or bioavailability enhancement. It will also provide an enhanced life cycle for drugs under patent coverage (life cycle extension).

This comprehensive report on novel drug delivery system focuses mainly on the oral and injectable formulations of pharmaceuticals and specialty companies. This report enumerates the various formulation technologies involved in making value added formulations, pharmaceutical applications and advantages of specific technologies. Wherever possible, marketed drugs using a similar technology have been discussed as proof of validation along with the status of additional pipeline. The discussed proprietary formulation technologies includes Colal, Glide SDI, Arestat, GeoClock, GeoMatrix, FlashTab, Lock Tab, Medusa, Eligen, Oradur, EnteriCare and Saber.

This report will be helpful for those pharma companies who are exploring novel opportunities for their growth by in-licensing formulation technology or value added pipeline drugs available/being studied in the market.

List Of Tables

Figure 1
Refractory MDS/ RR AML: Emerging Therapeutics
Refractory MDS/ RR AML: Emerging Therapeutics

List Of Figures


Innovative Packaging Industry Corp in Packaging Industry (Philippines)

Innovative Packaging Industry Corp is expected to invest strongly in research and development in order to ensure it can align with the evolving needs of its customers. This is also

USD 150View Report

Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report

Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the companys structure, operation, SWOT analysis,

USD 175View Report

2017 Vietnam Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.Highlights- Five-year test

USD 4250View Report

Global Pulmonary Drug Delivery Devices Market Research Report 2017

Notes:Production, means the output of Pulmonary Drug Delivery DevicesRevenue, means the sales value of Pulmonary Drug Delivery DevicesThis report studies Pulmonary Drug Delivery Devices in Global market, especially in North

USD 2900View Report

Global Transmucosal Drug Delivery Sales Market Report 2017

Notes:Sales, means the sales volume of Transmucosal Drug DeliveryRevenue, means the sales value of Transmucosal Drug DeliveryThis report studies sales (consumption) of Transmucosal Drug Delivery in Global market, especially in

USD 4000View Report

Europe Nasal Drug Delivery Market Report 2017

Notes:Sales, means the sales volume of Nasal Drug DeliveryRevenue, means the sales value of Nasal Drug DeliveryThis report studies sales (consumption) of Nasal Drug Delivery in Europe market, especially in

USD 3900View Report

Fill The Form For Sample Request
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


  • PDF    $ 2500
  • Site Licence    $ 5000
  • Enterprisewide Licence    $ 7500
$ 2500

Reports Details

Published Date : Jun 2013
No. of Pages :123
Country :Global
Category :Healthcare
Publisher :MP Advisors
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE


We Accept